All Stories

  1. Pharmacologic principles behind eye drop dosing: From pharmacokinetics to clinical practice
  2. Objective Assessment of Visual Workload in Video Display Terminal Workers Using a Non-Invasive Monitoring System
  3. Femto-DSAEK for deep posterior stromal opacity: a lamellar alternative to PK in failed DMEK
  4. Descemet's membrane endothelial keratoplasty with scraping without descemetorhexis (DMEK-SWD) in a failed penetrating keratoplasty
  5. Comparative efficacy of Nd : YAG laser peripheral iridotomy and surgical iridectomy in modulating perioperative subclinical inflammation after ...
  6. Corneal Stromal Thinning and Posterior Irregularity After DMEK: Clinical Observations and Biophysical Hypotheses
  7. Anterior Chamber Inflammation and Descemet Membrane Endothelial Keratoplasty
  8. Differential Diagnosis of Corneal Manifestations in Hypovitaminosis and Retinitis Pigmentosa
  9. Validation of a Deep Learning–Assisted Evaluation of Total Corneal Endothelial Cells Viability
  10. Congenital aniridia: European COST action ANIRIDIA‐NET guidelines for diagnosis, management and care
  11. Advanced imaging of corneal neovascularisation with a novel swept-source AS-OCTA system
  12. Atypical Endophthalmitis Following Artificial Corneal Endothelial Implantation
  13. Trypan blue-assisted iris cyst excision
  14. Evaluating the efficacy of postoperative topical antibiotics in cataract surgery: A systematic review and meta‐analysis
  15. Cataract surgery in megalocornea: A qualitative and quantitative evaluation of published literature
  16. Differentiation of human hyalocytes from induced pluripotent stem cells through ascorbic acid treatment
  17. Letter Regarding: Assessing Corneal Tomographic Changes in Fuchs Endothelial Corneal Dystrophy Over 1 Year: Scheimpflug Versus Anterior Segment Optical Coherence Tomography
  18. Repeatability of Pentacam HR in Keratoconus According to Two Different Scan Protocols: 25-3D Scan and 50-Cornea Fine
  19. Suprachoroidal injection of triamcinolone acetonide as adjuvant to surgical treatment of epiretinal membrane
  20. Comparative Analysis of Tomographic Indicators Forecasting Decompensation in Fuchs Endothelial Corneal Dystrophy
  21. Life-threatening complications in ophthalmic surgery: a systematic review
  22. Corneal Artificial Endothelial Layer (EndoArt): Literature Review and Our Experience
  23. Off-Centered Descemet Membrane Endothelial Keratoplasty Grafts: Impact and Resolution
  24. Utilising Narrative Medicine to Identify Key Factors Affecting Quality of Life in Dry Eye Disease: An Italian Multicentre Study
  25. Natural history of cerebral visual impairment in children with cerebral palsy
  26. Preoperative Posterior Stromal Ripples as Predictive Biomarkers of Visual Recovery After Descemet Membrane Endothelial Keratoplasty
  27. Multimodal imaging and histopathological evaluation in silicone oil keratopathy
  28. The incidence of severe complications in acanthamoeba keratitis: Qualitative and quantitative systematic assessment
  29. Corneal manifestations in bariatric surgery-related hypovitaminosis
  30. Cancer stem-like cells in uveal melanoma: novel insights and therapeutic implications
  31. Quality assurance in corneal transplants: Donor cornea assessment and oversight
  32. Topical Antiseptics in Minimizing Ocular Surface Bacterial Load Before Ophthalmic Surgery: A Randomized Controlled Trial
  33. Open-source, 3D printable IOL holder for detailed, smartphone-based anterior segment photography
  34. Double trouble in DMEK surgery: Learning experience and review of the literature
  35. Allogeneic serum eye drops Sjogren syndrome‐related dry eye disease: Clinical evaluation of the ocular surface and in vivo confocal microscopy of the cornea
  36. In‐vivo evaluation of corneal collagen fibrils pattern to detect Keratoconus
  37. Prevalence of tomographic features associated with subclinical oedema in Fuchs dystrophy across three commercially available corneal tomographers
  38. Role of heparin‐binding mediators in the resistance to anti‐VEGF therapies in diabetic retinopathy
  39. DMEK surgical training: An instructional guide on various wet-lab methods
  40. DMEK F-marking complication: case report and literature review
  41. Ocular phenotype and therapeutic interventions in keratitis-ichthyosis-deafness (KID) syndrome
  42. Preoperative surgeon evaluation of corneal endothelial status: the Viability Control of Human Endothelial Cells before Keratoplasty (V-CHECK) study protocol
  43. Antimicrobials and antiseptics: Lowering effect on ocular surface bacterial flora – A systematic review
  44. Artificial iris implantation in congenital aniridia: A systematic review
  45. Deep Learning Using Preoperative AS-OCT Predicts Graft Detachment in DMEK
  46. FGF-trapping hampers cancer stem-like cells in uveal melanoma
  47. Combined or sequential DMEK in cases of cataract and Fuchs endothelial corneal dystrophy—A systematic review and meta‐analysis
  48. A goat eye, wet lab model for training in Descemet membrane endothelial keratoplasty
  49. Incidence and management of early postoperative complications in lamellar corneal transplantation
  50. Role of Direct Supervision in the Learning Curve of Descemet Membrane Endothelial Keratoplasty Surgery
  51. Intraoperative OCT for Lamellar Corneal Surgery: A User Guide
  52. Predictability of the vault after implantable collamer lens implantation using OCT and artificial intelligence in White patient eyes
  53. Selective laser capsulotomy complications: Management and prevention
  54. Neurovisual profile in children affected by Angelman syndrome
  55. Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers
  56. Surgical goniolens for tag identification and removal in DMEK surgery
  57. Allogeneic Solid Platelet-Rich Plasma for Persistent Epithelial Neurotrophic Defects: A Protocol and Pilot Study
  58. Therapeutic Hyper-CL soft contact lens in Sjögren's syndrome
  59. COVID-19 and Clinically Isolated Syndrome: Coincidence or Causative Link? A 12-Month Follow-Up Case Report
  60. Comments on: Fine-needle diathermy for corneal vascularization
  61. Extended Overview of Ocular Phenotype with Recent Advances in Hypohidrotic Ectodermal Dysplasia
  62. Retinal and Corneal Changes Associated with Intraocular Silicone Oil Tamponade
  63. What empiric treatment should be given for suspected bacterial keratitis in Northern Italy?
  64. DMEK graft: One size does not fit all
  65. Myopia: Mechanisms and Strategies to Slow Down Its Progression
  66. COVID-19 AdenoviralVector Vaccine and Central Retinal Vein Occlusion
  67. Visual and Refractive Outcomes Following Laser Blended Vision With Non-linear Aspheric Micro-anisometropia (PRESBYOND) in Myopic and Hyperopic Patients
  68. Exploring the FGF/FGFR System in Ocular Tumors: New Insights and Perspectives
  69. Age-Related Effects on the Spectrum of Cerebral Visual Impairment in Children With Cerebral Palsy
  70. Update on Suture Techniques in Corneal Transplantation: A Systematic Review
  71. An Orthotopic Model of Uveal Melanoma in Zebrafish Embryo: A Novel Platform for Drug Evaluation
  72. SURGICAL OUTCOMES OF VITREOMACULAR TRACTION TREATED WITH FOVEAL-SPARING PEELING OF THE INTERNAL LIMITING MEMBRANE
  73. Vitreous from idiopathic epiretinal membrane patients induces glial-to-mesenchymal transition in Müller cells
  74. Two-Year Changes in Corneal Spherical Aberration After Laser-Assisted In Situ Keratomileusis and Photorefractive Keratectomy in Regular and Wavefront-Guided Ablations
  75. Neurodevelopmental Profile in Children Affected by Ocular Albinism
  76. Early visual training and environmental adaptation for infants with visual impairment
  77. Risk factors for postoperative eye pain in patients with non-painful eye disease undergoing pars plana vitrectomy: the VItrectomy Pain (VIP) study
  78. A novel quantitative analysis method for idiopathic epiretinal membrane
  79. Effect of COVID-19-related lockdown on ophthalmic practice in Italy: A report from 39 institutional centers
  80. VEGF-Independent Activation of Müller Cells by the Vitreous from Proliferative Diabetic Retinopathy Patients
  81. Topography/wavefront-guided photorefractive keratectomy combined with crosslinking for the treatment of keratoconus: preliminary results
  82. Changes in pupillometry associated with dissipated energy during phacoemulsification
  83. Gene expression analysis identifies two distinct molecular clusters of idiopatic epiretinal membranes
  84. Effectiveness and Safety of Topical Chlorhexidine and Vitamin E TPGS in the Treatment of Acanthamoeba Keratitis: A Survey on 29 Cases
  85. Angiogenesis-Inflammation Cross Talk in Diabetic Retinopathy: Novel Insights From the Chick Embryo Chorioallantoic Membrane/Human Vitreous Platform
  86. Effects of the first month of lockdown for COVID-19 in Italy: A preliminary analysis on the eyecare system from six centers
  87. FOVEA-SPARING VERSUS COMPLETE INTERNAL LIMITING MEMBRANE PEELING IN VITRECTOMY FOR THE TREATMENT OF MACULAR HOLES
  88. Pneumatic retinopexy preceded by drainage of subretinal fluid for the treatment of severe bullous retinal detachment
  89. PEELING OF THE INTERNAL LIMITING MEMBRANE WITH FOVEAL SPARING FOR TREATMENT OF DEGENERATIVE LAMELLAR MACULAR HOLE
  90. Correction: One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  91. One week of levofloxacin plus dexamethasone eye drops for cataract surgery: an innovative and rational therapeutic strategy
  92. Ocular Refraction at Birth and Its Development During the First Year of Life in a Large Cohort of Babies in a Single Center in Northern Italy
  93. Effects of an antioxidant protective topical formulation on retinal tissue of UV-exposed rabbits
  94. Central Serous Chorioretinopathy: Pathogenesis and Management
  95. Diabetic retinopathy, a vascular and inflammatory disease: Therapeutic implications
  96. EPIRETINAL MEMBRANE REMOVAL WITH FOVEAL-SPARING INTERNAL LIMITING MEMBRANE PEELING
  97. The Autocrine FGF/FGFR System in both Skin and Uveal Melanoma: FGF Trapping as a Possible Therapeutic Approach
  98. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an update
  99. Vascular Endothelial Growth Factor in the Vitreous of Proliferative Diabetic Retinopathy Patients: Chasing a Hiding Prey?
  100. Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications
  101. Treatment of exudative age‐related macular degeneration with aflibercept combined with pranoprofen eye drops or nutraceutical support with omega‐3: A randomized trial
  102. Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration
  103. Comparative assessment of intraocular inflammation following standard or heavy silicone oil tamponade: a prospective study
  104. POOR CONCORDANCE BETWEEN NON-INVASIVE AND LOCALLY INVASIVE TECHNIQUES OF EVALUATION OF MICROVASCULAR MORPHOLOGY IN THE DETECTION OF HYPERTROPHIC REMODELING OF SMALL RESISTANCE ARTERIES
  105. Comparison between invasive and noninvasive techniques of evaluation of microvascular structural alterations
  106. ranibizumab and indomethacin in neovascular age-related macular degeneration
  107. Carotid stiffness is significantly correlated with wall-to-lumen ratio of retinal arterioles
  108. New Methods to Study the Microcirculation
  109. Neonatal Assessment Visual European Grid (NAVEG): Unveiling neurological risk
  110. ILM peeling in nontractional diabetic macular edema: review and metanalysis
  111. 3D endothelial cell spheroid/human vitreous humor assay for the characterization of anti-angiogenic inhibitors for the treatment of proliferative diabetic retinopathy
  112. [PP.09.17] REPRODUCIBILITY OF THE EVALUATION OF THE WALL TO LUMEN RATIO OF RETINAL ARTERIOLES WITH TWO DIFFERENT NON-INVASIVE APPROACHES
  113. [OP.8C.03] COMPARISON BETWEEN THREE NON-INVASIVE TECHNIQUES OF EVALUATION MICROVASCULAR MORPHOLOGY VS. THE GOLD-STANDARD LOCALLY INVASIVE MICROMYOGRAPHY. PRELIMINARY DATA
  114. Ocular fundus photography with a smartphone device in acute hypertension
  115. Comparison of lercanidipine plus hydrochlorothiazide vs. lercanidipine plus enalapril on micro and macrocirculation in patients with mild essential hypertension
  116. Heavy and standard silicone oil: intraocular inflammation
  117. Comparison of half-dose photodynamic therapy and 689 nm laser treatment in eyes with chronic central serous chorioretinopathy
  118. Intravitreal Anti-Vascular Endothelial Growth Factor Drugs for Retinal Angiomatous Proliferation in Real-Life Practice
  119. Relationship between different subpopulations of circulating CD4+ T lymphocytes and microvascular or systemic oxidative stress in humans
  120. Inflammation and N-formyl peptide receptors mediate the angiogenic activity of human vitreous humour in proliferative diabetic retinopathy
  121. Controversies over the role of internal limiting membrane peeling during vitrectomy in macular hole surgery
  122. Trace elements and diabetes: Assessment of levels in tears and serum
  123. Spectral-domain optical coherence tomography findings in idiopathic lamellar macular hole
  124. Is aceruloplasminemia treatable? Combining iron chelation and fresh-frozen plasma treatment
  125. Effect of Autologous Serum Eye Drops in Patients with Sjögren Syndrome-related Dry Eye: Clinical and In Vivo Confocal Microscopy Evaluation of the Ocular Surface
  126. Reduced-fluence verteporfin photodynamic therapy plus ranibizumab for choroidal neovascularization in pathologic myopia
  127. Relationship Between Different Subpopulations of Circulating CD4+T-lymphocytes and Microvascular Structural Alterations in Humans
  128. Comparison of Smartphone Ophthalmoscopy With Slit-Lamp Biomicroscopy for Grading Vertical Cup-to-Disc Ratio
  129. [PP.21.05] RELATIONSHIP BETWEEN MICROVASCULAR STRUCTURE AND T REGULATORY LYMPHOCYTES OF SMALL RESISTANCE ARTERIES
  130. [OP.8D.06] OCULAR FUNDUS PHOTOGRAPHY WITH A SMARTPHONE DEVICE IN ACUTE HYPERTENSION
  131. Morphological and Functional Retinal Assessment in Epiretinal Membrane Surgery
  132. From the analysis of pharmacologic vitreolysis to the comprehension of ocriplasmin safety
  133. Zebrafish ( Danio rerio ) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases
  134. REDUCTION OF VITREOUS PROSTAGLANDIN E2 LEVELS AFTER TOPICAL ADMINISTRATION OF INDOMETHACIN 0.5%, BROMFENAC 0.09%, AND NEPAFENAC 0.1%
  135. Arteriolar Diameters in Glaucomatous Eyes with Single-Hemifield Damage
  136. Morphological and clinical characteristics of myopic posterior staphyloma in Caucasians
  137. Assessment of a smartphone-based camera for fundus imaging in animals
  138. INDICATIONS AND RESULTS OF A NEW L-SHAPED MACULAR BUCKLE TO SUPPORT A POSTERIOR STAPHYLOMA IN HIGH MYOPIA
  139. Pharmacokinetic and Pharmacodynamic Properties of Anti-VEGF Drugs After Intravitreal Injection
  140. Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration
  141. TREATMENT OF EXUDATIVE AGE-RELATED MACULAR DEGENERATION WITH RANIBIZUMAB COMBINED WITH KETOROLAC EYEDROPS OR PHOTODYNAMIC THERAPY
  142. Efficacy and vitreous levels of topical NSAIDs
  143. PP.27.10
  144. Antiangiogenic Effectiveness of the Urokinase Receptor-Derived Peptide UPARANT in a Model of Oxygen-Induced Retinopathy
  145. Effect of intravitreal ranibizumab injections on aqueous humour concentrations of vascular endothelial growth factor and pigment epithelium-derived factor in patients with myopic choroidal neovascularisation
  146. Therapeutic Potential of Anti-Angiogenic Multitarget N,O -Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy
  147. Comparison of Smartphone Ophthalmoscopy With Slit-Lamp Biomicroscopy for Grading Diabetic Retinopathy
  148. Development of ocular hypertension secondary to tamponade with light versus heavy silicone oil: A systematic review
  149. A Novel Device to Exploit the Smartphone Camera for Fundus Photography
  150. Current Trends about Inner Limiting Membrane Peeling in Surgery for Epiretinal Membranes
  151. Diabetic Retinopathy: Vascular and Inflammatory Disease
  152. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy
  153. Effects of a Long-Term Treatment With Aliskiren or Ramipril on Structural Alterations of Subcutaneous Small-Resistance Arteries of Diabetic Hypertensive Patients
  154. Diameters and Wall-to-Lumen Ratio of Retinal Arterioles in Patients with Retinal Vein Occlusion Before and After Treatment with Dexamethasone Intravitreal Implants
  155. Effect of Palmitoylethanolamide on Visual Field Damage Progression in Normal Tension Glaucoma Patients: Results of an Open-Label Six-Month Follow-Up
  156. Cystoid macular edema after pars plana vitrectomy for idiopathic epiretinal membrane
  157. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration: an overview
  158. Relationship of Wall-to-Lumen Ratio of Retinal Arterioles With Clinic and 24-Hour Blood Pressure
  159. Correlation between clinic and 24 hours blood pressure and wall-to-lumen ratio of retinal arterioles
  160. Infliximab
  161. Acute Dacryocystitis with Empyema of the Lacrimal Sac
  162. 5th International meeting on angiogenesis
  163. Anti-TNF therapy for juvenile idiopathic arthritis-related uveitis
  164. Effect of antihypertensive treatment on microvascular structure, central blood pressure and oxidative stress in patients with mild essential hypertension
  165. Results from a pilot study on amiodarone administration in monogenic frontotemporal dementia with granulin mutation
  166. Quality of vision in patients implanted with aspherical and spherical intraocular lens: Intraindividual comparison
  167. Tamponade or Filling Effect: Changes of Forces in Myopic Eyes
  168. Heavy Silicone Oil and Intraocular Inflammation
  169. Etiopathogenesis and Therapy of Epithelial Ingrowth after Descemet’s Stripping Automated Endothelial Keratoplasty
  170. Some Physicochemical Remarks on Spontaneous Emulsification of Vitreal Tamponades
  171. Evaluation of the Efficacy of 50% Autologous Serum Eye Drops in Different Ocular Surface Pathologies
  172. Macular Edema and Silicone Oil Tamponade
  173. Cognitive Dysfunction and Age-Related Macular Degeneration
  174. Clinical Analysis of Macular Edema with New Software for SD-OCT Imaging
  175. In vitro and ex vivo retina angiogenesis assays
  176. Neurotrophic Keratitis
  177. Ocular tissues and fluids oxidative stress in hares fed on verbascoside supplement
  178. Myopia onset and progression: can it be prevented?
  179. High doses of cobalt induce optic and auditory neuropathy
  180. Acute Dacryocystitis with Empyema of the Lacrimal Sac: Is Immediate Endoscopic Dacryocystorhinostomy Justified?
  181. Relationship between wall-to-lumen ratio of retimal arterioles and clinic and 24 hours blood pressure
  182. Aflibercept in wet AMD: specific role and optimal use
  183. Incidence rates of surgically treated rhegmatogenous retinal detachment among manual workers, non-manual workers and housewives in Tuscany, Italy
  184. A randomised controlled trial of ranibizumab with and without ketorolac eyedrops for exudative age-related macular degeneration
  185. Familial Exudative Vitreoretinopathy caused by a Homozygous Mutation inTSPAN12in a Cystic Fibrosis Infant
  186. A novel ex vivo murine retina angiogenesis (EMRA) assay
  187. Intravitreal Infliximab for Choroidal Neovascularization in Patients Refractory to Conventional Treatments
  188. Corneal oedema and its medical treatment
  189. Aqueous humor levels of vascular endothelial growth factor and adiponectin in patients with type 2 diabetes before and after intravitreal bevacizumab injection
  190. Novel aspects of Sjögren’s syndrome in 2012
  191. Recurrent Central Serous Chorioretinopathy after Peripheral Retinal Laser Photocoagulation: A Case Report
  192. INTRAVITREAL PEGAPTANIB SODIUM (MACUGEN) FOR TREATMENT OF MYOPIC CHOROIDAL NEOVASCULARIZATION
  193. Central Retinal Vein Occlusion Treated with Ozurdex: A Case Report and Review of Literature
  194. Inflammation and Macular Oedema after Pars Plana Vitrectomy
  195. Erythropoietin and Diabetic Retinopathy
  196. Topical Nonsteroidal Anti-Inflammatory Drugs for Macular Edema
  197. Vitreous Mediators in Retinal Hypoxic Diseases
  198. Mechanism of Inflammation in Age-Related Macular Degeneration: An Up-to-Date on Genetic Landmarks
  199. Proliferative Vitreoretinopathy after Eye Injuries: An Overexpression of Growth Factors and Cytokines Leading to a Retinal Keloid
  200. Short-time prone posturing is well-tolerated and reduces the rate of unintentional retinal displacement in elderly patients operated on for retinal detachment
  201. TNF-Alpha Levels in Tears: A Novel Biomarker to Assess the Degree of Diabetic Retinopathy
  202. P1.16 CORRELATION BETWEEN WALL-TO-LUMEN RATIO OF RETINAL ARTERIOLES AND CLINIC AND 24 HOURS BLOOD PRESSURE
  203. Intravitreal pegaptanib sodium (Macugen®) for treatment of diabetic macular oedema: a morphologic and functional study
  204. Intravitreal bevacizumab versus low-fluence photodynamic therapy for treatment of chronic central serous chorioretinopathy
  205. Systemic thromboembolic adverse events in patients treated with intravitreal anti-VEGF drugs for neovascular age-related macular degeneration
  206. Identification of mRNAs and proteins specifically associated with transformation in ocular malignant melanoma cells
  207. Correlation between visual acuity and OCT-measured retinal nerve fiber layer thickness in a family with ADOA and an OPA1 mutation
  208. Relationship between media-to-lumen ratio of subcutaneous small arteries and wall-to-lumen ratio of retinal arterioles evaluated noninvasively by scanning laser Doppler flowmetry
  209. Consensus on the diagnosis, treatment and follow-up of patients with age-related macular degeneration eligible for ranibizumab
  210. Defining reference values of trace elements in the tear film: Diagnostic methods and possible applications
  211. Reduction in retinal nerve fiber layer thickness in migraine patients
  212. Pseudo-Foster Kennedy syndrome in a young woman with meningioma infiltrating the superior sagittal sinus
  213. Proteomic Analyses of the Vitreous Humour
  214. Vitreous Analysis in the Management of Uveitis
  215. Mechanism of Inflammation in Age-Related Macular Degeneration
  216. 3.5 EFFECT OF SHORT-TERM TREATMENT WITH LERCANIDIPINE ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND STRUCTURAL ALTERATIONS IN RETINAL ARTERIOLES
  217. Structural Alterations in Small Resistance Arteries in Obesity
  218. Retinal Angiomatosis and Cystoid Macular Oedema in Coganʼs Syndrome
  219. Systemic Adverse Drug Reactions Secondary to Anti-VEGF Intravitreal Injection in Patients with Neovascular Age-Related Macular Degeneration
  220. Predicting the risk of diabetic retinopathy in type 2 diabetic patients
  221. Genetic Predictors of Response to Photodynamic Therapy
  222. Therapeutic Challenges to Retinitis Pigmentosa: From Neuroprotection to Gene Therapy
  223. Isolated sphenoid inflammatory diseases associated with visual impairment: 15-year experience at a single institution
  224. Clinical Evidence of Intravitreal Triamcinolone Acetonide in the Management of Age-Related Macular Degeneration
  225. Combined photodynamic therapy and intravitreal bevacizumab for idiopathic polypoidal choroidal vasculopathy: one-year follow-up
  226. Impact of Coagulation-Balance Gene Predictors on Efficacy of Photodynamic Therapy for Choroidal Neovascularization in Pathologic Myopia
  227. Inflammatory Mediators and Angiogenic Factors in Choroidal Neovascularization: Pathogenetic Interactions and Therapeutic Implications
  228. Low fluence rate photodynamic therapy combined with intravitreal bevacizumab for neovascular age-related macular degeneration
  229. INTRAVITREAL BEVACIZUMAB FOR TREATMENT-NAÏVE PATIENTS WITH SUBFOVEAL OCCULT CHOROIDAL NEOVASCULARIZATION SECONDARY TO AGE-RELATED MACULAR DEGENERATION
  230. Changes in neovascular choroidal morphology after intravitreal bevacizumab injection: prospective trial on 156 eyes throughout 12-month follow-up
  231. Endophthalmitis
  232. Multiple Strokes in a Newborn
  233. Selective Serotonin Reuptake Inhibitors: A Review of its Effects on Intraocular Pressure
  234. Verteporfin Photodynamic Therapy for Subfoveal Choroidal Neovascularization in Pathologic Myopia: A 12-Month Retrospective Review
  235. Intravitreal bevacizumab (Avastin®) injection for neovascular glaucoma: a survey on 23 cases throughout twelve-month follow-up
  236. Gonioscopic Findings in Patients with Type 1 Neurofibromatosis (Von Recklinghausen Disease)
  237. Effect of Ginkgo biloba extract on preexisting visual field damage in normal tension glaucoma
  238. Color Doppler Imaging of Ophthalmic Artery Blood Flow Velocity
  239. Diplopie Iatrogenique: Possible Responsabilite Professionelle
  240. Severe Corneoconjunctival Xerosis After Biliopancreatic Bypass for Obesity (Scopinaro's Operation)
  241. Cocaine-associated retinal vascular occlusion: Report of two cases
  242. Analysis of fibronectin, plasminogen activators and plasminogen in tear fluid as markers of corneal damage and repair